344
Productivity & Workflow355
Automation & Workflow225
Software Development251
Marketing & Growth193
AI Infrastructure & MLOps176
Writing & Content Creation204
Photography & Imaging156
Data & Analytics142
Design & Creative170
Customer Support133
Sales & Outreach125
Education & Learning131
Voice & Speech135
Operations & Admin87
Tyler Shultz says it can be hard to check AI claims, and he warns investors could be misled like they were during the Theranos era.
In short: Former Theranos employee and whistleblower Tyler Shultz says the rush to invest in AI could make it easier for some companies to mislead people.
Tyler Shultz, a key whistleblower in the Theranos scandal, is warning that today’s AI boom creates “a great opportunity to go deceive people.” Shultz helped expose that Theranos’ blood testing technology did not work as promised, even though the company reached a roughly $10 billion valuation.
In an interview with The San Francisco Standard, Shultz said the old habit of backing a founder after a short meeting should be “over.” He said investors need to take more care because giving large amounts of money to founders also gives them power, and that power can be misused.
Shultz also argued that AI can be especially hard to properly evaluate. He said it can be difficult to tell what is truly new versus something that mainly repackages existing tools, like a “ChatGPT wrapper” (think of it like putting a new label on a product that is mostly the same inside). He worries that when companies raise huge sums at very high valuations, the pressure and excitement can make careful checking easier to skip.
Expect more calls for stronger “due diligence,” which means investors asking for clearer proof before writing big checks. For regular people, this can affect which AI products reach the market, and whether they are safe and reliable. Shultz’s warning is also a reminder to be cautious of bold AI claims that do not come with clear evidence.
Source: TechCrunch AI